EGFR-mediated apoptosis via STAT3
Nicole M Jackson1, Brian P Ceresa1
1Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, United States.
Abstract:
The Epidermal Growth Factor Receptor (EGFR) is a cell surface receptor with primary implications in cell growth in both normal and malignant tissue. Paradoxically, cell lines that hyperexpress the EGFR have been documented to undergo receptor-mediated apoptosis. The underlying mechanism by which EGF-induced apoptosis occurs however remains inexplicit. In an attempt to identify this mechanism, we assessed downstream effectors of EGFR in MDA-MB-468 cells during conditions of EGF-induced apoptosis. The effector assessment revealed STAT3 as a potential mediator of EGF-induced apoptosis. Alternative strategies for activating STAT3, independent of EGFR stimulation, resulted in the induction of the apoptotic pathways. A reduction in STAT3 expression via RNAi resulted in a significant attenuation of EGF-induced PARP cleavage. Our findings support STAT3 as a positive mediator of EGF-induced apoptosis in MDA-MB-468 cells.
Insights
Signal transducer and activator of transcription 3 (STAT3) mediates Epidermal Growth Factor Receptor (EGFR) signaling to induce apoptosis in MDA-MB-468 cells. This study identifies STAT3 as a key mediator in EGFR-induced programmed cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The Epidermal Growth Factor Receptor (EGFR) plays a crucial role in cell growth and is implicated in both normal and malignant tissues.
- Paradoxically, cancer cell lines overexpressing EGFR can undergo receptor-mediated apoptosis, a mechanism that remains poorly understood.
- Understanding EGFR signaling in apoptosis is critical for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the underlying mechanism of Epidermal Growth Factor (EGF)-induced apoptosis in cancer cells.
- To identify downstream effectors of EGFR signaling involved in apoptosis.
- To investigate the role of Signal transducer and activator of transcription 3 (STAT3) in EGF-induced apoptosis.
Main Methods:
- Assessed downstream effectors of EGFR in MDA-MB-468 cells under EGF stimulation.
- Utilized alternative strategies to activate STAT3 independently of EGFR.
- Reduced STAT3 expression using RNA interference (RNAi).
- Measured Poly (ADP-ribose) polymerase (PARP) cleavage as an indicator of apoptosis.
Main Results:
- STAT3 was identified as a potential mediator of EGF-induced apoptosis.
- Independent activation of STAT3 induced apoptotic pathways.
- RNAi-mediated reduction of STAT3 significantly attenuated EGF-induced PARP cleavage.
- EGFR signaling in MDA-MB-468 cells promotes apoptosis via STAT3.
Conclusions:
- STAT3 acts as a positive mediator in the process of EGF-induced apoptosis.
- Targeting STAT3 may represent a therapeutic strategy for cancers with EGFR overexpression.
- This research provides novel insights into the molecular mechanisms of EGFR-driven apoptosis.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades


